☆ 4.6 Letter

Inclusion and exclusion criteria in phase III trials with systemic agents in psoriasis: the external validity of drug development

BRITISH JOURNAL OF DERMATOLOGY (2016)

Journal

BRITISH JOURNAL OF DERMATOLOGY

Volume 175, Issue 3, Pages 636-638

Publisher

WILEY-BLACKWELL

DOI: 10.1111/bjd.14622

Keywords

-

Categories

Dermatology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.